Lv5
1370 积分 2021-05-26 加入
Glucagon-like peptide-1 receptor agonists and hair loss: A systematic review and meta-analysis
23天前
已完结
Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials
23天前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
24天前
已完结
Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
24天前
已完结
Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation
24天前
已完结
Preclinical and First‐In‐Human Evaluation of Ribupatide ( HRS9531 ), a Dual GLP ‐1/ GIP Receptor Agonist
24天前
已完结
Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity
27天前
已关闭
Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity
27天前
已完结
Abstracts from the 43rd Annual Meeting of the Obesity Society at Obesityweek® November 4-7, 2025
27天前
已完结
Real‐world persistence and dose titration of GLP ‐1 receptor agonists in type 2 diabetes: A UK population‐based cohort study by obesity and cardiovascular disease status
1个月前
已完结
皖公网安备34019202002308
